MoCRA Cosmetic Facility Registration Renewals: What Brands Need to Know Before July 2026

If your cosmetic manufacturing facility registered with FDA in early 2024 — which is when the mandatory MoCRA registration deadline first hit — your renewal deadline may already be here. Facilities that registered by the initial July 1, 2024 deadline must renew by July 1, 2026 at the latest, and many have renewal dates earlier than that based on their specific initial registration date. This is not a grace period situation. Failure to renew is a prohibited act under federal law.

Here is what cosmetic brands, manufacturers, and responsible persons need to know and do now.

---

What Is MoCRA and Why Does Renewal Matter?

The Modernization of Cosmetics Regulation Act of 2022 — MoCRA — fundamentally changed how the U.S. regulates cosmetics. For the first time, cosmetic product facility registration and product listing became mandatory rather than voluntary. Those requirements became enforceable on July 1, 2024, and as of now, over 14,000 cosmetic product facilities are registered with FDA.

The 2026 renewal cycle is the first real compliance test of the biennial renewal framework. Under section 607(a)(2) of the FD&C Act, as amended by MoCRA, every registered facility must renew its registration every two years from the date of initial registration. On February 11, 2026, FDA updated its Cosmetics Direct electronic submission portal with new Registration Status and Renewal Date fields and began sending automated renewal reminders to registered facilities.

The existence of automated reminders does not reduce your legal obligation. If your portal shows a renewal date approaching or passed, you are responsible.

---

The July 1, 2026 Deadline: What It Means

Facilities that registered on or before the initial July 1, 2024, mandatory deadline must renew by July 1, 2026. But the actual renewal deadline for any given facility depends on its specific initial registration date — not all deadlines are July 1. If the FDA received your initial registration on February 20, 2024, your renewal date is February 20, 2026. That date may have already passed.

The practical step right now is to log into Cosmetics Direct, check the Registration Status and Renewal Date fields for each of your registered facilities, and confirm whether renewal has been completed or is imminent.

Two renewal options are available: a full biennial renewal for registrations where information has changed, and an abbreviated renewal for registrations with no changes since the last submission. FDA recommends initiating the renewal process at least two weeks before the due date to allow for possible portal delays.

---

What Happens If You Miss the Deadline?

Failure to renew a cosmetic product facility registration is a prohibited act under Section 301(hhh) of the FD&C Act. Consequences can include:

• FDA enforcement action, including Warning Letters
• Import holds and border detentions for foreign facilities
• Facility suspension, which can prevent products from entering U.S. commerce
• Downstream consequences with retailers, Amazon, and other platforms that increasingly require MoCRA-compliant registration as part of onboarding
• Complications in due diligence for investors or acquirers who now routinely check MoCRA status

MoCRA’s registration and listing database is active and searchable. FDA can identify non-compliant facilities more easily than it could under the prior voluntary program.

---

Facility Registration Is Not a One-Time Task

Many companies treated MoCRA registration as a one-time project completed in 2023 or 2024. That approach will create compliance problems now.

Cosmetic facility registration must be renewed every two years. FDA also expects companies to update registration information when information changes. If your facility has had changes in contact information, product categories, brand names manufactured there, or responsible person information since initial registration, those updates need to be reflected in the renewal.

Registration coordination between brands and their contract manufacturers is a common failure point. The brand may assume the manufacturer has handled registration. The manufacturer may assume the brand has handled product listing. That gap can produce a mismatch between what FDA has on file and what is actually being sold — which creates both a legal compliance issue and a practical problem when a retailer or due-diligence reviewer pulls the records.

---

Facility Registration vs. Product Listing: Two Separate Obligations

MoCRA creates two distinct compliance tracks that are often confused.

Facility registration (under section 607 of the FD&C Act) identifies each facility that manufactures or processes cosmetic products. Registration must be renewed biennially. The responsible submission vehicle is Cosmetics Direct (Form FDA 5066).

Cosmetic product listing (under section 607 of the FD&C Act) identifies each marketed cosmetic product, including product category, full ingredient list, and responsible person information. Product listings must be updated annually when information changes. The submission vehicle is also Cosmetics Direct (Form FDA 5067).

A brand that does not manufacture may still have product listing obligations as the responsible person. A contract manufacturer may have facility registration obligations even if it does not own the brand. Whether a company needs one or both depends on its specific role in the supply chain.

---

Common MoCRA Mistakes to Avoid in 2026

Assuming the contract manufacturer handled everything. A contract manufacturer’s facility registration does not complete the brand’s product listing obligations. The brand should confirm exactly what was submitted, who submitted it, whether the information was accurate, and whether it remains current.

Not updating product listings when things change. Formulations change. Labels change. Responsible person information changes. Manufacturing sites change. If FDA records are not updated, the company has a mismatch between what FDA has on file and what it is actually selling.

Treating MoCRA as only a registration requirement. Registration and listing are the most immediate obligations, but MoCRA also covers adverse event records, serious adverse event reporting to FDA, safety substantiation, and labeling compliance. Registration renewal is a good occasion to review all of these.

Making drug claims on cosmetic products. A product marketed as a cosmetic can become an unapproved drug if the company claims it will treat or prevent disease or affect the structure or function of the body. Claims such as “treats eczema,” “heals acne,” “repairs collagen,” “reduces inflammation,” or “prevents infection” may create drug issues depending on context. FDA’s enforcement attention to “cosmeceutical” positioning has increased under MoCRA. Companies should review websites, labels, social media, influencer scripts, before-and-after photos, and customer testimonials.

Not maintaining safety substantiation. MoCRA requires responsible persons to maintain records supporting adequate substantiation of safety for cosmetic products. This is especially important for products in sensitive categories — leave-on formulas, products involving children, products with novel ingredients, and higher-risk categories.

---

A Note on GMPs and Fragrance Allergen Labeling

Two MoCRA provisions are still developing and worth monitoring:

GMP requirements. MoCRA authorizes the FDA to establish good manufacturing practice requirements for cosmetics through rulemaking, but that formal GMP rule has not yet been finalized. In the interim, the FDA has indicated that ISO 22716 — the international standard for cosmetics GMP — serves as a recognized benchmark. Companies should align manufacturing, quality control, documentation, and personnel practices with ISO 22716 now rather than waiting for a final rule.

Fragrance allergen labeling. MoCRA directs FDA to require disclosure of fragrance allergens on cosmetic labels. This requirement is pending rulemaking — it has not yet been finalized. A proposed rule is anticipated. Companies should monitor this development and begin gathering full allergen data from fragrance suppliers in advance, but should not represent the requirement as currently in force.

---

What Cosmetic Companies Should Do Now

The most immediate action is to check your Cosmetics Direct portal for the Registration Status and Renewal Date of each registered facility and confirm who controls the account. Then work through the following:

• Confirm each facility’s registration is active and renewal timing
• Confirm who controls the Cosmetics Direct account and has authority to submit renewals
• Review cosmetic product listings for accuracy and currency
• Confirm responsible person information is current and correct
• Confirm U.S. agent information for any foreign facilities
• Review labels and marketing claims for drug-claim risk
• Confirm adverse event and serious adverse event reporting procedures are in place
• Review safety substantiation files for marketed products
• Confirm your contract manufacturer’s registration status — a brand cannot legally list its products if its contract manufacturer has not maintained an active facility registration

This review is especially important before launching new products, changing manufacturers, importing cosmetics, onboarding with major retailers, or preparing for investor due diligence.

---

Practical Takeaway

MoCRA has changed cosmetic compliance in the United States permanently. Facility registration and product listing are mandatory, and biennial renewals are now part of the regulatory calendar. The first major renewal wave is due by July 1, 2026 — and for many facilities, the deadline is already past. If your company registered in early 2024, your deadline may have already come and gone.

The compliance picture is not just about registration. FDA’s MoCRA framework is actively enforced, and the gap between what FDA has on file and what a company is actually doing creates real legal and commercial exposure.

Need help with MoCRA facility registration renewal, product listing, or a full compliance review? Contact FDA Atty before FDA, a retailer, or a due-diligence reviewer raises the issue. You can also learn more about our cosmetics regulatory services.

---

Frequently Asked Questions

When is the MoCRA cosmetic facility registration renewal deadline? Renewal deadlines are based on each facility’s initial registration date. Facilities that registered by the initial mandatory deadline of July 1, 2024 must renew by July 1, 2026 at the latest — and many have earlier deadlines based on their specific registration date. Log into FDA’s Cosmetics Direct portal to see your facility’s specific Renewal Date.

Does MoCRA apply to my cosmetic brand if I use a contract manufacturer? Probably yes, in at least one respect. While the contract manufacturer is responsible for registering its manufacturing facility, the brand — as the responsible person whose name appears on the product label — typically has cosmetic product listing obligations. The two obligations are separate. You should confirm with your contract manufacturer what has been submitted and verify that your product listings are current and accurate.

What is the difference between facility registration and product listing under MoCRA? Facility registration identifies each physical location that manufactures or processes cosmetic products and must be renewed every two years. Cosmetic product listing identifies each marketed cosmetic product — including its category, ingredients, and responsible person — and must be updated annually when information changes. A company may have one or both obligations depending on its role. Failure to comply with either is a prohibited act under federal law.

What happens if I miss a MoCRA renewal deadline? Failure to renew is a prohibited act under Section 301(hhh) of the FD&C Act. Consequences can include FDA Warning Letters, import holds and border detentions for foreign manufacturers, and potential facility suspension. Missing renewal can also create problems with retailer onboarding, Amazon compliance requests, and investor due diligence, as these increasingly rely on active MoCRA registration status.

What GMP standard applies to cosmetic manufacturers under MoCRA right now? MoCRA authorizes FDA to set GMP requirements through rulemaking, but the formal cosmetics GMP rule has not yet been finalized. In the interim, FDA has recognized ISO 22716 — the international GMP standard for cosmetics — as a relevant benchmark. Companies should align their manufacturing, quality control, and documentation practices with ISO 22716 now rather than waiting for the final rule.

Do I need to worry about fragrance allergen labeling now? Not yet as a legal requirement — but you should be preparing. MoCRA directs FDA to require fragrance allergen disclosure on cosmetic labels through rulemaking, but that rule is still pending. A proposed rule is anticipated. Companies should begin gathering full allergen data from fragrance suppliers now so they are ready to comply when the rule is finalized.

---

This post is intended for general informational purposes and does not constitute legal advice. MoCRA compliance requirements are fact-specific and depend on your company’s role, product categories, and registration history. Contact an FDA regulatory attorney for advice specific to your situation.